AWAG
ARS Wealth Advisors Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Buy |
7,453
+202
| +3% | +$37.5K | 0.16% | 64 |
|
|
2025
Q1 | $1.52M | Sell |
7,251
-22
| -0.3% | -$4.61K | 0.21% | 54 |
|
|
2024
Q4 | $1.29M | Buy |
7,273
+905
| +14% | +$161K | 0.18% | 56 |
|
|
2024
Q3 | $1.26M | Buy |
6,368
+261
| +4% | +$51.5K | 0.15% | 60 |
|
|
2024
Q2 | $1.05M | Buy |
6,107
+568
| +10% | +$97.4K | 0.14% | 65 |
|
|
2024
Q1 | $1.01M | Sell |
5,539
-192
| -3% | -$35K | 0.14% | 67 |
|
|
2023
Q4 | $888K | Sell |
5,731
-3,619
| -39% | -$561K | 0.13% | 69 |
|
|
2023
Q3 | $1.39M | Buy |
9,350
+3,819
| +69% | +$569K | 0.23% | 56 |
|
|
2023
Q2 | $745K | Buy |
5,531
+1,466
| +36% | +$198K | 0.12% | 78 |
|
|
2023
Q1 | $648K | Sell |
4,065
-26
| -0.6% | -$4.14K | 0.12% | 73 |
|
|
2022
Q4 | $661K | Sell |
4,091
-95
| -2% | -$15.4K | 0.11% | 77 |
|
|
2022
Q3 | $562K | Buy |
4,186
+1
| +0% | +$134 | 0.09% | 90 |
|
|
2022
Q2 | $641K | Sell |
4,185
-208
| -5% | -$31.9K | 0.09% | 94 |
|
|
2022
Q1 | $712K | Sell |
4,393
-324
| -7% | -$52.5K | 0.12% | 64 |
|
|
2021
Q4 | $639K | Buy |
4,717
+25
| +0.5% | +$3.39K | 0.11% | 76 |
|
|
2021
Q3 | $506K | Buy |
+4,692
| New | +$506K | 0.09% | 79 |
|